Human VEGF QuantiGlo ELISA Kit | 安迪生物R&D QVE00B 产品信息

产品简要

公司名称 :

安迪生物R&D

产品类型 :

ELISA/assay

产品名称 :

Human VEGF QuantiGlo ELISA Kit

QVE00B

规格 :

1 Kit

价格 :

750美元

更多信息或购买 :

安迪生物R&D 产品网页

文章摘录数: 22

参考文献
Fu J, Shinjo T, Li Q, St Louis R, Park K, Yu M, et al. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy. JCI Insight. 2022;7: pubmed 出版商
Abrahamsson A, Capodanno A, Rzepecka A, Dabrosin C. Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women. Oncotarget. 2017;8:92134-92142 pubmed 出版商
Xie M, Dart D, Guo T, Xing X, Cheng X, Du H, et al. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer. 2018;21:41-54 pubmed 出版商
Bader A, Klose K, Bieback K, Korinth D, Schneider M, Seifert M, et al. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro. PLoS ONE. 2015;10:e0138477 pubmed 出版商
Lecce L, Lam Y, Lindsay L, Yuen S, Simpson P, Handelsman D, et al. Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis. Mol Endocrinol. 2014;28:1487-501 pubmed 出版商
Abu El Asrar A, Nawaz M, Kangave D, Mairaj Siddiquei M, Geboes K. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res. 2013;2013:539658 pubmed 出版商
Leifler K, Svensson S, Abrahamsson A, Bendrik C, Robertson J, Gauldie J, et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J Immunol. 2013;190:4420-30 pubmed 出版商
Gupta P, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation. 2011;8:47 pubmed 出版商
Chambers S, Clouser M, Baker A, Roe D, Cui H, Brewer M, et al. Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin Cancer Res. 2010;16:5320-8 pubmed 出版商
Saarinen N, Warri A, Dings R, Airio M, Smeds A, MAKELA S. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int J Cancer. 2008;123:1196-204 pubmed 出版商
Bendrik C, Robertson J, Gauldie J, Dabrosin C. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008;68:3405-12 pubmed 出版商
Etto L, Lacerda E, Baiocchi O, Silva V, Dalboni M, Alves A, et al. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2008;49:257-64 pubmed 出版商
Carroll V, Ashcroft M. Regulation of angiogenic factors by HDM2 in renal cell carcinoma. Cancer Res. 2008;68:545-52 pubmed 出版商
Anelli V, Gault C, Cheng A, Obeid L. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem. 2008;283:3365-75 pubmed
Kut C, Mac Gabhann F, Popel A. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer. 2007;97:978-85 pubmed
Chen Y, Hu Y, Lu K, Flannery J, Ma J. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem. 2007;282:34420-8 pubmed
Sutton K, Hayat S, Chau N, Cook S, Pouyssegur J, Ahmed A, et al. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene. 2007;26:3920-9 pubmed
Carroll V, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res. 2006;66:6264-70 pubmed
Liu Y, Mueller B. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun. 2006;344:1263-70 pubmed
Feltis B, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med. 2006;173:1201-7 pubmed
Cartwright L, Farhat W, Sherman C, Chen J, Babyn P, Yeger H, et al. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A. 2006;77:390-5 pubmed
Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik S, et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 2005;65:7249-58 pubmed

图像

图像 1 :

Human VEGF Chemiluminescent ELISA Cell Culture Supernate/Serum/Plasma/Saliva Standard Curve

产品信息

品牌 :

R&D Systems

MasterCode :

QVE00B

SKU号 :

QVE00B

产品名称 :

Human VEGF QuantiGlo ELISA Kit

描述 :

The VEGF Chemiluminescent ELISA from QVE00B quantifies 5.5 hours in 5.99 pg/ml.

靶标 :

血管内皮生长因子

类别 :

ELISAs

单位尺寸 :

1 Kit

物种 :

人类

特异性 :

Natural and recombinant human VEGF. This assay also recognizes recombinant human VEGF165b.

基因符号 :

血管内皮生长因子A

assay length :

5.5小时

elisaSampleTypes :

Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL), Saliva (50 uL), Urine (50 uL)

elisaSensitivity :

5.99 pg/mL

elisaRange :

6.40 - 20000 pg/mL

应用 :

酶联免疫吸附测定

美元 :

750美元

产品细节 :

The QuantiGlo Human VEGF Chemiluminescent Immunoassay is a 5.5 hour solid phase ELISA designed to measure VEGF165 levels in cell culture supernates, serum, plasma, saliva, and urine. It contains Sf 21-expressed recombinant human VEGF165 and antibodies raised against the recombinant protein. Results obtained for naturally occurring human VEGF and recombinant human VEGF121 showed linear curves that were parallel to the standard curves obtained using the QuantiGlo kit standards. These results indicate that this kit can be used to determine relative mass values for natural human VEGF.

别名 :

MVCD1, VAS, 血管内皮生长因子, 血管通透性因子, 促血管因子, 血管内皮生长因子A, 血管内皮生长因子-A, VEGFMGC70609, VPF, VPFvascular血管内皮生长因子

储存 :

Store the unopened product at 2 - 8 °C. Do not use past expiration date.

更多信息或购买 :

安迪生物R&D 产品网页

公司信息

安迪生物R&D

上海市长宁区延安西路726号华敏翰尊国际大厦24A1

info@rndsystemschina.com.cn

http://www.rndsystemschina.com.cn

21 52380373

公司总部: 美国

R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.